News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Marie-Louise Alamaa appointed interim CFO at PledPharma

June 24, 2020

PledPharma AB (STO: PLED) today announced that Marie-Louise Alamaa takes on the position as interim CFO at PledPharma. She will join the company in July.

Marie-Louise has extensive experience within finance and controlling from public companies. Her previous positions include CFO at Index Invest International AB, various senior finance positions at Crucell Sweden AB (previously SBL Vaccin AB) and Senior Consultant at the listed gaming company Stillfront Group AB.
She has studied economics at the universities of Uppsala and Stockholm, Sweden, with a particular focus on accounting and auditing.
A process for the recruitment of a permanent CFO have been initiated.
“I am very happy to get Marie-Louise on board at PledPharma. She has a proven track-record of broad and relevant work experience in a listed environment, and with a problem-solving and team-oriented attitude, she will make an excellent addition to the team,” said Nicklas Westerholm, CEO, PledPharma.



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10